Tarsus Pharmaceuticals (TARS) Short-term Investments (2021 - 2026)
Tarsus Pharmaceuticals (TARS) posted Short-term Investments of $173.08 million for Q3 2026, down 40.1% from $289.11 million a year earlier and down 29.4% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals' Short-term Investments came in at $233.63 million, up 18.9% from FY2024.
- Annual Short-term Investments shows a four-year compound annual growth rate of 369.0% (FY2021 to FY2025).
- In prior years, Tarsus Pharmaceuticals' Short-term Investments was $196.56 million in FY2024, $2.5 million in FY2023 (-98.3%), $145.37 million in FY2022 and $483,000 in FY2021.
- The Q3 2026 figure stands as the lowest quarterly Short-term Investments since Q3 2024.
- On a year-over-year basis, Short-term Investments increased in five of the last seven quarters, with growth averaging 45.0%.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q3 2024, with growth of 596.3%; the weakest was Q4 2023, with a decline of 98.3%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $245.1 million (Q2 2026), $286.54 million (Q1 2026) and $233.63 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Tarsus Pharmaceuticals | 3.64 Bn | 2.07 Bn | 180.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 173.08 Mn |
| Jun 30, 2026 | 245.10 Mn |
| Mar 31, 2026 | 286.54 Mn |
| Dec 31, 2025 | 233.63 Mn |
| Sep 30, 2025 | 289.11 Mn |
| Jun 30, 2025 | 284.50 Mn |
| Mar 31, 2025 | 232.13 Mn |
| Dec 31, 2024 | 196.56 Mn |
| Sep 30, 2024 | 140.74 Mn |
| Jun 30, 2024 | 142.49 Mn |
| Mar 31, 2024 | 104.82 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 20.21 Mn |
| Jun 30, 2023 | 71.46 Mn |
| Mar 31, 2023 | 135.22 Mn |
| Dec 31, 2022 | 145.37 Mn |
| Sep 30, 2022 | 57.08 Mn |
| Mar 31, 2022 | 291,000.00 |
| Dec 31, 2021 | 483,000.00 |
API Access
Tarsus Pharmaceuticals Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();